MoneyWorks4Me

Pharmaids Pharmaceuticals informs about board meeting

02 Feb 2019 Evaluate

Pharmaids Pharmaceuticals has informed that the meeting of the Board of Directors of the Company is scheduled on 12/02/2019, to consider, approve and take on record the un-audited standalone financial results of the company for the quarter ended on 31st December, 2018.

The above information is a part of company’s filings submitted to BSE.

Pharmaids Pharma Share Price

32.24 0.06 (0.19%)
21-Aug-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma. Inds. 1900.90
Dr. Reddys Labs. 1175.00
Cipla 1426.20
Lupin 2193.00
Zydus Lifesciences 1120.00
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: